BE754111A - Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparation - Google Patents
Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparationInfo
- Publication number
- BE754111A BE754111A BE754111DA BE754111A BE 754111 A BE754111 A BE 754111A BE 754111D A BE754111D A BE 754111DA BE 754111 A BE754111 A BE 754111A
- Authority
- BE
- Belgium
- Prior art keywords
- cycloandrostanes
- 7beta
- 3alpha
- 5alpha
- methyl
- Prior art date
Links
- VVUQRXPUVKXAIO-XFUVECHXSA-N 19-nor-5-androstenediol Chemical class C1[C@@H](O)CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC=C21 VVUQRXPUVKXAIO-XFUVECHXSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84587769A | 1969-07-29 | 1969-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE754111A true BE754111A (fr) | 1971-01-29 |
Family
ID=25296306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE754111D BE754111A (fr) | 1969-07-29 | Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparation |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3580937A (de) |
| BE (1) | BE754111A (de) |
| CH (1) | CH533095A (de) |
| DE (1) | DE2035738A1 (de) |
| FR (1) | FR2059572B1 (de) |
| GB (1) | GB1279186A (de) |
| IL (1) | IL34974A (de) |
| NL (1) | NL7009586A (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5714481A (en) * | 1983-08-02 | 1998-02-03 | Research Corporation Technologies, Inc. | Derivatives of 5-androsten-17 ones and 5-androstan-17-ones |
| DE3485647D1 (de) * | 1983-08-02 | 1992-05-21 | Research Corp | Steroide und diese enthaltende therapeutische zusammensetzungen. |
| US5804576A (en) * | 1983-08-02 | 1998-09-08 | Research Corporation Technologies, Inc. | Derivatives of 5-androsten-17-ones and 5-androstan-17-ones |
| US5656621A (en) * | 1983-08-02 | 1997-08-12 | Research Corporation Tech., Inc. | Steroids useful as anti-cancer and anti-obesity agents |
| US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
| US5028631A (en) * | 1987-11-25 | 1991-07-02 | Schwartz Arthur G | Homoandrostan-17-one and homoandrosten-17-ones |
| US4898694A (en) * | 1987-11-25 | 1990-02-06 | Schwartz Arthur G | 17-Hydroxy-steroids |
| US5001119A (en) * | 1987-11-25 | 1991-03-19 | Schwartz Arthur G | 16-substituted androstanes and 16-substituted androstenes |
| DK1955700T3 (da) | 1999-09-30 | 2011-05-23 | Harbor Biosciences Inc | Terapeutisk behandling af androgenreceptor-betingede lidelser |
| ES2738526T3 (es) | 2011-10-14 | 2020-01-23 | Sage Therapeutics Inc | Compuestos 19-norpregnano 3,3-disustituidos, composiciones y usos de los mismos |
| NZ773177A (en) | 2012-01-23 | 2022-09-30 | Sage Therapeutics Inc | Neuroactive steroid formulations and methods of treating cns disorders |
| IL275725B (en) | 2012-08-21 | 2022-08-01 | Sage Therapeutics Inc | Treatment methods for epilepsy and status epilepticus |
| AU2014256229B2 (en) | 2013-04-17 | 2018-10-04 | Sage Therapeutics, Inc. | 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| RS60420B1 (sr) * | 2013-04-17 | 2020-07-31 | Sage Therapeutics Inc | 19-nor neuroaktivni steroidi za metode lečenja |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| PL3021852T3 (pl) | 2013-07-19 | 2021-07-05 | Sage Therapeutics, Inc. | Neuroaktywne steroidy, kompozycje i ich zastosowania |
| JP6466942B2 (ja) | 2013-08-23 | 2019-02-06 | セージ セラピューティクス， インコーポレイテッド | 向神経活性ステロイド、組成物、及びその使用 |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| HUE051488T2 (hu) | 2014-10-16 | 2021-03-01 | Sage Therapeutics Inc | Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére |
| WO2016061527A1 (en) | 2014-10-16 | 2016-04-21 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| US10774108B2 (en) | 2014-11-27 | 2020-09-15 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| PL3250210T3 (pl) | 2015-01-26 | 2021-07-26 | Sage Therapeutics, Inc. | Kompozycje i sposoby leczenia zaburzeń OUN |
| JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| WO2017156103A1 (en) | 2016-03-08 | 2017-09-14 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JP7049313B2 (ja) | 2016-07-11 | 2022-04-06 | セージ セラピューティクス， インコーポレイテッド | Ｃ１７、ｃ２０、およびｃ２１置換神経刺激性ステロイドおよびそれらの使用方法 |
| ES2992037T3 (es) | 2016-07-11 | 2024-12-05 | Sage Therapeutics Inc | Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización |
| CR20240234A (es) | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629) |
-
0
- BE BE754111D patent/BE754111A/xx unknown
-
1969
- 1969-07-29 US US845877A patent/US3580937A/en not_active Expired - Lifetime
-
1970
- 1970-06-16 GB GB29169/70A patent/GB1279186A/en not_active Expired
- 1970-06-24 CH CH955170A patent/CH533095A/de not_active IP Right Cessation
- 1970-06-29 NL NL7009586A patent/NL7009586A/xx unknown
- 1970-07-18 DE DE19702035738 patent/DE2035738A1/de active Pending
- 1970-07-22 IL IL34974A patent/IL34974A/xx unknown
- 1970-07-28 FR FR7027781A patent/FR2059572B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IL34974A (en) | 1974-06-30 |
| FR2059572A1 (de) | 1971-06-04 |
| FR2059572B1 (de) | 1974-08-23 |
| CH533095A (de) | 1973-01-31 |
| NL7009586A (de) | 1971-02-02 |
| IL34974A0 (en) | 1970-09-17 |
| US3580937A (en) | 1971-05-25 |
| DE2035738A1 (de) | 1971-02-11 |
| GB1279186A (en) | 1972-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE754111A (fr) | Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparation | |
| BE772309A (fr) | Nouveaux alpha, epsilon-di-s-triazinyl-perfluoropolyoxaalcane et leur procede de preparation | |
| BE752512A (fr) | Nouvelles polyaryl-ether-sulfones et leur procede de preparation | |
| BE747492A (fr) | Nouveaux steroides physiologiquement actifs, et leur procede defabrication | |
| BE749035A (fr) | Composes disazoiques, leur procede de preparation et leur emploi | |
| BE746737A (fr) | Nouveaux composes azoliques, leur procede de preparation et leur emplo | |
| BE746738A (fr) | Nouveaux composes azoliques, leur procede de preparation et leur emplo | |
| BE772739A (fr) | Nouveaux 17-chlorosteroides, leur procede de preparation et leur utilisation | |
| BE753314A (fr) | Nouveaux pyridine-bis-(hydroxyaryl-ethers) et leur procede de preparation | |
| BE760402A (fr) | Nouveaux derives bis-aroxazolyliques, leur procede de preparation et leur utilisation | |
| BE820383A (fr) | Nouveaux d-homo.steroides et leur procede de preparation | |
| BE770295A (fr) | Nouveaux composes tensio-actifs et leur procede de preparation | |
| BE795019A (fr) | Composes anthraquinoniques, leur procede de preparation et leur utilisation | |
| BE817351A (fr) | Nouveaux steroides et leur procede de preparation | |
| BE766008A (fr) | Nouveaux composes antibacteriens et leur procede de preparation | |
| BE751562A (fr) | 4-pyrazolidinols 1,2-disubstitues et leur procede de preparation | |
| BE751923A (fr) | Nouveaux aminoaryl-ethers et leur procede de preparation | |
| BE770294A (fr) | Nouveaux composes tensio-actifs et leur procede de preparation | |
| BE835427A (fr) | Nouveaux methylenesteroides, et leur procede de preparation | |
| BE795636A (fr) | Nitroimidazolylpyrimidines, et leur procede de preparation | |
| BE753632A (fr) | Nitrofuryl-aminoalkoxy-pyrimidines et leur procede de preparation | |
| BE752462A (fr) | Nouveaux composes pyrazolidiniques, leur procede de preparationet leursapplication | |
| BE800121A (fr) | Nouveaux triazolyl-naphtalimides et leur procede de preparation, | |
| BE825801A (fr) | Composes azatetracycliques oxygenes, et leur procede de preparation | |
| BE789443A (fr) | Nouveaux composes azonaphtimidazole, leur procede de preparation et leur application |